In a prespecified 3-year analysis of the sham-controlled SPYRAL HTN-ON MED trial in uncontrolled hypertension on 1–3 drugs, renal denervation lowered 24-hour ambulatory systolic BP by 4.7 mm Hg and office systolic BP by 7.5 mm Hg vs sham, with similar medication burden.
RCT
Kandzari et al. Three-Year Durability of Radiofrequency Renal Denervation: SPYRAL HTN-ON MED